跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
潘 秀玲
教授
,
癌症生物學與藥物研發研究所
合聘教授
,
新藥研發產業博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
成員
,
臺北醫學大學新藥開發研究中心
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0001-7449-3539
電子郵件
slpan
tmu.edu
tw
h-index
4882
引文
41
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2025
每年研究成果
概覽
指紋
網路
專案
(39)
研究成果
(174)
資料集
(16)
類似的個人檔案
(10)
指紋
查看啟用 Shiow-Lin Pan 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
14%
Antiangiogenic
15%
Anticarcinogen
51%
Antiproliferative Activity
22%
Antitumor Activity
40%
Bradykinin
18%
Breast Cancer
16%
Calcium Ion
24%
Cancer Growth
20%
Caspase
15%
Caspase 3
23%
Colorectal Cancer
55%
Cytotoxicity
23%
Disease
16%
Epidermal Growth Factor Receptor
13%
Histone Deacetylase
27%
Histone Deacetylase 6
44%
Histone Deacetylase Inhibitor
44%
Hydroxamic Acid
15%
Hypoxia Inducible Factor 1
12%
IC50
41%
Indazole Derivative
14%
Inositol Phosphate
13%
Lificiguat
13%
Liver Cell Carcinoma
25%
Lung Cancer
19%
Malignant Neoplasm
100%
Mitogen Activated Protein Kinase
21%
Mitogen Activated Protein Kinase 3
11%
Mouse
18%
Mouse Model
11%
Neoplasm
43%
Non Small Cell Lung Cancer
31%
Nuclear Factor
11%
Pancreas Cancer
24%
Phosphatidylinositide
21%
Phosphotransferase
38%
Prostate Cancer
40%
Protein Kinase C
13%
Protein P53
13%
Renal Cell Carcinoma
13%
Restenosis
16%
STAT3 Protein
12%
Structure Activity Relationship
12%
Tubulin
38%
Tumor Growth
47%
Vasculotropin
12%
Virtual Screening
18%
Vorinostat
24%
Western Blot
20%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
20%
Anticancer
29%
Antineoplastic Activity
14%
Antiproliferative Activity
7%
Autophagy
6%
Binding Protein
7%
Cancer Cell
63%
Carcinogenesis
6%
Caspase
18%
Caspase 3
10%
Cell Cycle
12%
Cell Death
14%
Cell Growth
9%
Cell Motility
7%
Cell Proliferation
9%
Cell Viability
7%
Complement Factor B
6%
Cytotoxicity
12%
Dephosphorylation
7%
Drug Resistance
6%
Dynamics
11%
Eicosanoid Receptor
7%
Endoplasmic Reticulum Stress
6%
G1 Phase
6%
HDAC6
16%
Heat Shock Protein
8%
High-Mobility Group
6%
Histone Deacetylase
19%
Hypoxia Inducible Factor 1
10%
IC50
17%
Integrin-Linked Kinase
10%
Kinase
21%
Mammalian Target of Rapamycin
7%
Microtubule Assembly
11%
Mitochondrial Membrane Potential
8%
Mitochondrion
9%
Mitosis Inhibition
13%
MUC1
6%
P53
8%
Phosphotransferase
21%
Protease-Activated Receptor 2
6%
Protein Stability
6%
Signal Transduction
23%
Tau
11%
Tubulin
15%
Tumor Progression
16%
Tyrosine Phosphorylation
10%
Upregulation
6%
Vascular Endothelial Growth Factor
7%
Wild Type
6%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
6%
Amino Terminal Sequence
6%
Angiogenesis
9%
Anticarcinogen
9%
Antimitotic Agent
6%
Antineoplastic Activity
15%
Cancer Cell
34%
Cancer Growth
9%
Cancer Therapy
13%
Cell Cycle Progression
5%
Cell Proliferation
11%
Cell Viability
5%
Colorectal Cancer
27%
Endothelial Cell
6%
HDAC1
5%
Histone Deacetylase
15%
Histone Deacetylase 6
7%
Histone Deacetylase Inhibitor
13%
Human Umbilical Vein Endothelial Cell
7%
IC50
5%
In Vitro
27%
Malignant Neoplasm
8%
Metastatic Carcinoma
13%
Mitogen-Activated Protein Kinase
5%
Mitosis Inhibition
11%
Neoplasm
9%
Ovarian Cancer
10%
Pancreas Cancer
13%
Phosphoinositide 3-Kinase
5%
Phosphotransferase
7%
Programmed Cell Death
33%
Protein P53
7%
Signal Transduction
10%
STAT3 Protein
12%
Sulfonyl
6%
Tissue Inhibitor of Metalloproteinase 3
6%
Tubulin
12%
Tumor Angiogenesis
14%
Tumor Progression
17%
Upregulation
9%
Vascular Smooth Muscle Cell
8%
Vorinostat
7%
Xenograft
11%
